NCT03689712 2023-10-24
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
Galera Therapeutics, Inc.
Phase 3 Completed
Galera Therapeutics, Inc.
US Oncology Research
Vigilant Biosciences, Inc.
Swedish Orphan Biovitrum
National Institutes of Health Clinical Center (CC)
National Center for Complementary and Integrative Health (NCCIH)
RxKinetix